Mangoceuticals, Inc. (MGRX) Stock Statistics & Valuation Metrics

Mangoceuticals, Inc. has a market cap or net worth of $18.96M. The enterprise value is ―.

Mangoceuticals, Inc. has 10,535,791 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mangoceuticals, Inc.’s return on equity (ROE) is -0.62 and return on invested capital (ROIC) is -56.30%.

The current PE Ratio of Mangoceuticals, Inc. is ―. Mangoceuticals, Inc.’s PEG ratio is 0.01.

In the last 12 months, Mangoceuticals, Inc. had revenue of 615.87K and earned -8.71M in profits. Earnings per share was -4.84.

In the last 12 months, operating cash flow was -5.83M and capital expenditures 4.00, giving a free cash flow of -5.83M billion.

Mangoceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Mangoceuticals, Inc. upcoming earnings date is ―, ―.

Mangoceuticals, Inc. as a current ratio of 0.05, with Debt / Equity ratio of 3.27%

In the past 12 months, Mangoceuticals, Inc. has paid 0.00 in taxes.

Mangoceuticals, Inc. EV to EBITDA ratio is -0.62, with an EV/FCF ratio of -1.02.

Mangoceuticals, Inc. has $101.02K in cash and marketable securities with $630.12K in debt, giving a net cash position of -$529.10K billion.

Gross margin is 61.00%, with operating margin of -1294.42%, and net profit margin of -1413.60%.

The average price target for Mangoceuticals, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―